@Article{Abdelaziz2020,
journal="Contemporary Oncology/Współczesna Onkologia",
issn="1428-2526",
volume="24",
number="4",
year="2020",
title="Tolerability and outcome of sunitinib by giving 4/2 schedule versus 2/1 schedule in metastatic renal cell carcinoma patients: a prospective randomized multi-centric Egyptian study",
author="Abdelaziz, Lobna A.
and Taha, Heba F.
and M. Ali, Magid
and Abdelgawad, Marwa I.
and Elwan, Amira",
pages="221--228",
doi="10.5114/wo.2020.102802",
url="http://dx.doi.org/10.5114/wo.2020.102802"
}